title: Novel POMGnT1 mutations cause muscle-eye-brain disease in Chinese patients.
abstract: Muscle-eye-brain (MEB) disease is a congenital muscular dystrophy (CMD) phenotype characterized by hypotonia at birth, brain structural abnormalities and ocular malformations. To date, few MEB cases have been reported in China where clinical recognition and genetic confirmatory testing on a research basis are recent developments. Here, we report the clinical and molecular genetics of three MEB disease patients. The patients had different degrees of muscle, eye and brain symptoms, ranging from congenital hypotonia, early-onset severe myopia and mental retardation to mild weakness, independent walking and language problems. This confirmed the expanding phenotypic spectrum of MEB disease with varying degrees of hypotonia, myopia and cognitive impairment. Brain magnetic resonance imaging showed cerebellar cysts, hypoplasia and characteristic brainstem flattening and kinking. Four candidate genes (POMGnT1, FKRP, FKTN and POMT2) were screened, and six POMGnT1 mutations (four novel) were identified, including five missense and one splice site mutation. Pathogenicity of the two novel variants in one patient was confirmed by POMGnT1 enzyme activity assay, protein expression and subcellular localization of mutant POMGnT1 in HeLa cells. Transfected cells harboring this patient's L440R mutant POMGnT1 showed POMGnT1 mislocalization to both the Golgi apparatus and endoplasmic reticulum. We have provided clinical, histological, enzymatic and genetic evidence of POMGnT1 involvement in three unrelated MEB disease patients in China. The identification of novel POMGnT1 mutations and an expanded phenotypic spectrum contributes to an improved understanding of POMGnT1 structure-function relationships, CMD pathophysiology and genotype-phenotype correlations, while underscoring the need to consider POMGnT1 in Chinese MEB disease patients.
authors.affiliation: Department of Pediatrics, Peking University First Hospital, Beijing, 100034, China.
authors.forename: Hui
authors.initials: H
authors.lastname: Jiao
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Manya
authors.forename: Shuo
authors.initials: S
authors.lastname: Wang
authors.forename: Yanzhi
authors.initials: Y
authors.lastname: Zhang
authors.forename: Xiaoqing
authors.initials: X
authors.lastname: Li
authors.forename: Jiangxi
authors.initials: J
authors.lastname: Xiao
authors.forename: Yanling
authors.initials: Y
authors.lastname: Yang
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Kobayashi
authors.forename: Tatsushi
authors.initials: T
authors.lastname: Toda
authors.forename: Tamao
authors.initials: T
authors.lastname: Endo
authors.forename: Xiru
authors.initials: X
authors.lastname: Wu
authors.forename: Hui
authors.initials: H
authors.lastname: Xiong
mesh_terms: D000595:Amino Acid Sequence; D044466:Asian People / Q000235:genetics*; D001483:Base Sequence; D001921:Brain / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D002681:China; D004789:Enzyme Activation; D019066:Facies; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008969:Molecular Sequence Data; D018482:Muscle, Skeletal / Q000473:pathology; D009154:Mutation; D017351:N-Acetylglucosaminyltransferases / Q000235:genetics* / Q000378:metabolism; D010375:Pedigree; D010641:Phenotype; D011296:Prenatal Diagnosis; D016415:Sequence Alignment; D058494:Walker-Warburg Syndrome / Q000175:diagnosis / Q000235:genetics*
chemical_list: D017351:N-Acetylglucosaminyltransferases; C443106:protein O-mannose beta-1,2-N-acetylglucosaminyltransferase